Marie-Claude Lavallée

Beaudry MM, Carignan D, Foster W, Lavallee MC, Aubin S, Lacroix F, Poulin E, Lachance B, Després P, Beaulieu L, Vigneault E, Martin AG

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

Clin Transl Radiat Oncol, 40 , 2023, ISSN: 2405-6308.

Résumé | Liens:

Lavallée MC, Cantin A, Monéger F, Lefebvre M, Foster W, Vigneault E, Beaulieu L

Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology

Brachytherapy, 20 (6), 2021.

Résumé | Liens:

Tho D, Lavallee MC, Beaulieu L

Performance of an enhanced afterloader with electromagnetic tracking capabilities for channel reconstruction and error detection

Med Phys, 48 (8), 2021.

Résumé | Liens:

Ben Aicha I, Hathout L, Carignan D, Després P, Lavallée MC, Aubin S, Beaulieu L, Lacroix F, Foster W, Martin AG, Vigneault E

Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost

Brachytherapy, 19 (5), 2020.

Résumé | Liens:

Guimond E, Lavallée MC, Foster W, Vigneault É, Guay K, Martin AG

Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes

Radiother Oncol, 133 , 2019.

Résumé | Liens:

Vigneault E, Martell K, Taussky D, Husain S, Delouya G, Mbodji K, Piotte J, Magnan S, Despres P, Lavallee MC, Aubin S, Beaulieu L, Foster W, Martin AG

Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?

Int J Radiat Oncol Biol Phys, 100 (5), 2018.

Résumé | Liens:

Vigneault E, Mbodji K, Magnan S, Després P, Lavallée MC, Aubin S, Beaulieu L, Foster W, Martin AG

High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes

Radiother Oncol, 124 (1), 2017.

Résumé | Liens:

St-Amant P, Foster W, Froment MA, Aubin S, Lavallee MC, Beaulieu L

Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography

Brachytherapy, 16 (4), 2017.

Résumé | Liens:

Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L

Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy

Cureus, 8 (9), 2016.

Résumé | Liens:

Vigneault E, Mbodji K, Beaudet ME, Despres P, Lavallee MC, Martin AG, Foster W, Aubin S, Beaulieu L

Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost?

Radiother Oncol, 121 (2), 2016.

Résumé | Liens: